Partnership simplifies digital data flows between Veeva RIM and Certara’s CoAuthor™ generative AI solution for regulatory and medical writing
“Medical writers are embracing generative AI like CoAuthor to cut first-draft time by 30%. The integration with Veeva Rim allows us to deliver a seamless, end-to-end regulatory writing experience that drives greater value,” said Christopher Bouton, Chief Technology Officer at Certara.
Certara（サターラ）について
サターラは、モデリング＆シミュレーション・ソフトウェアと技術を用いて、従来の創薬・開発を変革し、医薬品をよりスピーディーに患者さんに届けることをミッションとしています。製薬、教育機関、規制当局のお客様 2,400人以上、70ヵ国にてサターラの技術やサービスが活用されています。詳細は弊社ホームページをご覧ください。
サターラの問い合わせ先：
Sheila Rocchio
[email protected]
報道機関の皆様：
赤津笑美 (emi.akatsu@certara.com)
[email protected]
AIを活用したソリューションで規制文書を効率化
Pharmaceutical regulatory writing can be overwhelming. Medical writers spend countless hours on compiling, reviewing, and formatting documents. Mistakes in this critical process can lead to significant delays in drug approvals, thus impacting patient care. The emergence of AI has brought new opportunities to streamline medical writing processes. However, implementing AI into regulatory writing requires an industry-specific approach beyond everyday AI applications’ basics. Certara is revolutionizing regulatory writing with an industry-specific GenAI solution. This white paper explores how your organization can deploy AI safely and securely to enable efficiency while ensuring accuracy
FAQs
What is the Certara–Veeva partnership about?
This partnership integrates Certara’s CoAuthor™ generative AI solution with Veeva’s regulatory document management systems. It simplifies digital data flows, enabling regulatory writers to seamlessly access and use source files from Veeva Vault without manual imports.
How does this integration benefit regulatory writers?
Regulatory writers can now:
- Quickly source and update content from Veeva Vault directly in CoAuthor.
- Spend less time managing document transfers and more time focused on writing and analysis.
- Collaborate more effectively with data providers to meet tight submission deadlines.
Why is this important for regulatory submissions?
Life sciences teams often face challenges with rapidly changing study data, which delays drafting and submission readiness. By providing near real-time data access and automated content integration, this collaboration accelerates document preparation, reduces friction, and helps bring therapies to patients faster.
Who can use the integrated solution?
The integration is available to organizations that use both Certara CoAuthor and Veeva Vault as part of their regulatory writing and submission processes.
What makes this partnership unique?
This collaboration combines Certara’s expertise in generative AI with Veeva’s robust data management capabilities. The result is a solution that not only automates document creation but also ensures accuracy and compliance by leveraging real-time data.
Where can I learn more about Certara CoAuthor and Veeva Vault?
Visit the Certara CoAuthor webpage for more details about CoAuthor. For information on Veeva Vault and its capabilities, explore the Veeva Vault Platform.
